Novartis is betting that AI is the ‘next great tool’ for finding new, cutting-edge medicines. Here’s how the $220 billion drug giant is using it (NVS)
|01/29/2019||Posted by BusinessMediaguide.Com under General World News||
- Artificial intelligence could improve the expensive, slow process of developing drugs.
- Novartis is investing in AI, which executive Jay Bradner calls the “next great tool” for making new medicines. But the technology also isn’t quite there yet, Bradner said.
- Bradner, who leads Novartis’s drug research and development, spoke with Business Insider at the World Economic Forum in Davos, Switzerland last week.
- Here’s how the $220 billion Swiss drug giant is already using AI, and where the technology could be most promising.
DAVOS, Switzerland — Developing new medications is a notoriously expensive, slow, and failure-ridden process.
Using artificial intelligence, though, read more >>>